Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention. Yuan D, Wang P, Jia S, Zhang C, et al. Atherosclerosis 2022 Oct 25. pii: S0021-9150(22)01495.

Read + Share

Amedeo Smart

Independent Medical Education